What are the top internal and external challenges that Ranbaxy is facing?
Ranbaxy is going through a big change internally. Fortunately it is split in two parts — ownership change which took place last year and leadership change which is happening now. The bigger change was when Malvinder and Singh family sold out their stakes. The fact, that Malvinder stayed around for a year didn’t make that change feel as dramatic. In India, being a promoter-led company, there are lots of emotions etc. attached. The good part is despite the change, the senior management at Ranbaxy, has accepted the change and have handled it in a very mature manner. This may be because the ownership change had already taken place. Ranbaxy is a large MNC company with the senior management having decent credibility for employees to feel comfortable. Externally, situation doesn’t change too much. We’ve been part of the team that has taken decisions over the last few years. What can you tell us about the Daiichi Sankyo-Ranbaxy hybrid business model? The hybrid model has huge potential. We nee
